Scientists studying samples from the asteroid Bennu have found that it contains a remarkable mix of materials — some of which formed long before the sun even existed. Taken together, the findings, ...

Superluminal Medicines Inc. and Eli Lilly and Co. are collaborating in a deal to develop cardiometabolic disease and obesity therapies by aiming at undisclosed G protein-coupled receptor targets. The ...

Astrologer Lisa Stardust talks with PEOPLE about the meaning behind Taylor Swift's lucky number 13 in numerology Getty If you consider yourself a Swiftie, then chances are you’re no stranger to Taylor ...

Eli Lilly and Co (NYSE:LLY) has entered into a $1.3 billion deal with Superluminal Medicines to develop small-molecule drugs through artificial intelligence (AI) to treat obesity and other ...

Superluminal and Eli Lilly collaborate to develop small molecule therapeutics targeting GPCRs for cardiometabolic diseases and obesity. Superluminal's AI-driven platform integrates structural biology, ...

Eli Lilly and Co. is collaborating with Boston-based Superluminal Medicines to use artificial intelligence to discover small-molecule drugs for cardiometabolic disease and obesity in an agreement ...

Eli Lilly recently faced legal challenges as Texas Attorney General Ken Paxton filed a lawsuit against the company, accusing it of bribery and inducement, which might weigh heavily on its reputation.

Eli Lilly recently collaborated with Superluminal Medicines to advance therapeutics targeting cardiometabolic diseases, potentially offering significant financial opportunities. Despite this promising ...

Company to receive an upfront and near-term payments, including an equity investment, as well as additional development and commercial milestones, and tiered royalties BOSTON, Aug. 14, 2025 ...